> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves New Epclusa Indication
- URL: https://www.fdaweb.com/fda-approves-new-epclusa-indication/
- Published: 2020-07-15T12:00:00.000Z
- Updated: 2026-09-14T16:21:20.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147198

FDA says it has approved changes to the labeling for Gilead’s Epclusa (sofosbuvir and velpatasvir) to provide for its use in treating chronic HCV infection in treatment-naïve and treatment-experienced liver transplant recipients without cirrhosis or with compensated cirrhosis. An agency [notice](http://s2027422842.t.en25.com/e/es?s=2027422842&e=352714&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=1da26d2a1e9d4a66bd0f0207302ee3dc&elqaid=13375&elqat=1&ref=fdaweb.com) summarizes the specific changes to the Adverse Reactions, Clinical Pharmacology, and Clinical Studies sections of the labeling.